Literature DB >> 15243561

c-myc and bcl-2 Expression in supraglottic squamous cell carcinoma of the larynx.

Ali Ozdek1, Sarp Sarac, M Umut Akyol, Arzu Sungur, Taner Yilmaz.   

Abstract

OBJECTIVES: To evaluate the expression and prognostic significance of c-myc and bcl-2 oncogenes in squamous cell carcinoma (SCC) of the supraglottic larynx. Study design A retrospective cohort study of 61 patients who underwent surgery for SCC of the supraglottic larynx. Gender, age, TNM status, operative procedure, recurrences, and disease-free survival periods were recorded.
METHODS: Hematoxylin and eosin-stained sections were reexamined for grade, invasion of tumor margins, lymphovascular invasion, lymphocyte infiltration, and perineural invasion. Immunohistochemical detection of c-myc and bcl-2 oncogenes was performed using monoclonal antibodies.
RESULTS: No correlation was observed between either c-myc or bcl-2 and the clinical and histopathologic parameters. Survival analysis revealed no correlation of either c-myc (P = 0.88) or bcl-2 (P = 0.85) with the disease-free survival. c-myc expression was found to be significantly higher in bcl-2-positive patients (P = 0.001).
CONCLUSION: Neither c-myc nor bcl-2 had shown to be prognostic factor for laryngeal carcinoma in this present study. Correlation between c-myc and bcl-2 supports the experimental observations of cooperative action between these two genes in tumorigenesis.

Entities:  

Mesh:

Year:  2004        PMID: 15243561     DOI: 10.1016/j.otohns.2004.02.015

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

Review 1.  MYC and the control of apoptosis.

Authors:  Steven B McMahon
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

2.  FOXQ1 is overexpressed in laryngeal carcinoma and affects cell growth, cell cycle progression and cell invasion.

Authors:  Jie Zhang; Wei Li; Song Dai; Xuhui Tai; Jianping Jia; Xing Guo
Journal:  Oncol Lett       Date:  2015-07-23       Impact factor: 2.967

3.  Predicting transition from oral pre-malignancy to malignancy via Bcl-2 immuno-expression: Evidence and lacunae.

Authors:  Ruby Dwivedi; Shaleen Chandra; Divya Mehrotra; Vineet Raj; Rahul Pandey
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-19

Review 4.  The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma.

Authors:  Federico Maria Gioacchini; Matteo Alicandri-Ciufelli; Giuseppe Magliulo; Corrado Rubini; Livio Presutti; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-03       Impact factor: 2.503

5.  MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis.

Authors:  Shuang Fu; Yan Guo; Hong Chen; Zhen-Ming Xu; Guang-Bin Qiu; Ming Zhong; Kai-Lai Sun; Wei-Neng Fu
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

6.  Bcl-2 and c-Myc expression in oral dysplasia and oral squamous cell carcinoma: An immunohistochemical study to assess tumor progression.

Authors:  N Pallavi; Govind Raj K Nalabolu; Santhosh Kumar S Hiremath
Journal:  J Oral Maxillofac Pathol       Date:  2018 Sep-Dec

7.  mTORC2 promotes cell survival through c-Myc-dependent up-regulation of E2F1.

Authors:  Zhipeng Zou; Juan Chen; Anling Liu; Xuan Zhou; Qiancheng Song; Chunhong Jia; Zhenguo Chen; Jun Lin; Cuilan Yang; Ming Li; Yu Jiang; Xiaochun Bai
Journal:  J Cell Biol       Date:  2015-10-12       Impact factor: 10.539

8.  Altering MYC phosphorylation in the epidermis increases the stem cell population and contributes to the development, progression, and metastasis of squamous cell carcinoma.

Authors:  Xiaoyan Wang; Ellen M Langer; Colin J Daniel; Mahnaz Janghorban; Vivian Wu; Xiao-Jing Wang; Rosalie C Sears
Journal:  Oncogenesis       Date:  2020-09-07       Impact factor: 7.485

9.  Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines.

Authors:  Marinela Bostan; Mirela Mihaila; Georgiana Gabriela Petrica-Matei; Nicoleta Radu; Razvan Hainarosie; Cristian Dragos Stefanescu; Viviana Roman; Carmen Cristina Diaconu
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.